News

Depression in children, just like adults, is a far cry from "I am having a bad day", and causes persistent sadness or ...
Israel knows how to prepare for war. It’s time we learn how to prepare for what comes after — a mental health crisis that ...
Many of us feel sluggish or less social when it’s colder. But seasonal affective disorder is more than just a slump.
Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...
University of California, San Diego researchers say CBD can help ease autism symptoms. In the first controlled clinical trial, doctors used CBD on boys with autism. Researchers say two-thirds showed ...
Although the company withheld detailed findings from the study of treatment-resistant depression, analysts at Stifel called ...
A single dose of a synthetic, proprietary formulation of psilocybin (COMP360) was found to improve symptoms in patients with treatment-resistant ...
A new study from a group of scientists led by Queen Mary University of London, published in the British Journal of Psychiatry ...
Compass Pathways' psilocybin-based depression therapy reduced the severity of symptoms in a closely watched study, but shares of the biotech firm plunged more than 46% to a record low on Monday as the ...
Compass Pathways says a single dose of its synthetic psilocybin significantly reduced depression symptoms in patients who ...
Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.
A recent study published in the Journal of Affective Disorders found a stronger link between heatwaves and mental health issues among students living in rural areas ...